Shioda, Toshi

Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses

Vandenberg, L. N., Colborn, T., Hayes, T. B., Heindel, J. J., Jacobs, D. R., Lee, D.-H., Shioda, T., Soto, A. M., vom Saal, F. S., Welshons, W. V., et al. (2012) · Endocrine Reviews

Effects and risks of endocrine disrupting chemicalsEstrogen and related hormone effects

Cited by 3,209

MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis

Najafi-Shoushtari, S. H., Kristo, F., Li, Y., Shioda, T., Cohen, D. E., Gerszten, R. E., & Näär, A. M. (2010) · Science

Cholesterol and Lipid MetabolismMicroRNA in disease regulation

Cited by 957

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Niederst, M. J., Sequist, L. V., Poirier, J. T., Mermel, C. H., Lockerman, E. L., Garcia, A. R., Katayama, R., Costa, C., Ross, K. N., Moran, T., et al. (2015) · Nature Communications

Lung Cancer Treatments and MutationsLung Cancer Research Studies

Cited by 647

Synthetic lethal interaction of combined BCL-XL and MEK inhibition promotes tumor regressions in KRAS mutant cancer models

Corcoran, R. B., Cheng, K. A., Hata, A. N., Faber, A. C., Ebi, H., Coffee, E. M., Greninger, P., Brown, R. D., Godfrey, J. T., Cohoon, T. J., et al. (2013) · Cancer Cell

Melanoma and MAPK PathwaysProtein Kinase Regulation and GTPase Signaling

Cited by 377

Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP

Walker, A. K., Yang, F., Jiang, K., Ji, J.-Y., Watts, J. L., Purushotham, A., Boss, O., Hirsch, M. L., Ribich, S., Smith, J. J., et al. (2010) · Genes & Development

Sirtuins and Resveratrol in MedicineCancer, Lipids, and Metabolism

Cited by 357

Prenatal Exposure to BPA Alters the Epigenome of the Rat Mammary Gland and Increases the Propensity to Neoplastic Development

Dhimolea, E., Wadia, P. R., Murray, T. J., Settles, M. L., Treitman, J. D., Sonnenschein, C., Shioda, T., & Soto, A. M. (2014) · PLoS ONE

Effects and risks of endocrine disrupting chemicalsEpigenetics and DNA Methylation

Cited by 104